The U.S. Food and Drug Administration (FDA) approved NEXIUM® delayed release capsules in children ages 12 to 17 for the short-term treatment of gastroesophageal reflux disease (GERD). NEXIUM was tested in adolescents ages 12 to 17 in a randomized, double-blind parallel group study in which a total of 149 patients, ages 12 to 17, with clinically diagnosed GERD were treated with either NEXIUM 20mg or NEXIUM 40 mg once a day for up to eight weeks. Reported side effects included headache,...
Read moreThe North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN) is in the process of updating the guidelines... Read more »
I was a long-time sufferer with heartburn and was diagnosed with Barrett's esophagus a few years ago. While my symptoms have been under... Read more »
Dr. Todd Eisner answers some questions readers have posted in the last few weeks. Find new information on natural remedies for heartburn,... Read more »
I have been experiencing a lot of difficulty swallowing and underwent an endoscopy that was normal. What can this be? While it was correct... Read more »
Scintigraphy may become the newest tool to detect acid reflux in children. Research from Pakistan shows scintigraphy to be highly effective... Read more »
A well-taken patient history is the first step to establishing a diagnosis of GERD. If the patient has the classic heartburn and regurgitation... Read more »
Source: HealthCentral Encyclopedia
Gastroesophageal reflux disease (GERD) is a digestive disorder that affects the lower esophageal sphincter - LES, (where the muscle connects the... Read more »